Arencibia Associates' systems are in operation today in Fortune 500 companies,
creating value and profitability for the world's leading manufacturers of biotech,
pharmaceutical, aerospace, automotive, semiconductor, chemical and specialty
metals products. Our technologies increase your bottom line by reducing operating
and supply chain costs.

By
recycling argon in your semiconductor or metals facility, you not only save millions
of dollars a year in operating expenses and considerably reduce your vulnerability to
the rising price of argon, but you also increase the cost competitiveness of your
operation and of your product. As a result, in addition to baseline operational
savings, many customers have experienced increased sales and capacity.

Solvents waste and VOCs are a liability and an expense.  So is power.  Taking
solvent waste and liquified VOCs and converting them to electricity on site eliminates
both the liability and the expense and saves you millions of dollars a year in solvent
disposal and utility costs.

The active ingredients for the highly profitable statin drugs Lipitor(R) and Crestor(R)
are made in AAI
integrated reactor systems. Every batch load results in unparalleled
product uniformity and chemical stability, as well as a product yield five times greater
than that of a conventional low temperature reactor. That's more bang for your buck,
and a direct improvement of your bottom line.

As with our reactor systems, more and more pharmaceutical companies are relying
on our
shell freezers for greater yield in their production of vaccines. Less wasted
product means reduced associated operating costs and increased profit.
COPYRIGHT ARENCIBIA ASSOCIATES, INC. AND/OR ARENCIBIA ASSOCIATES EQUIPMENT SERVICES, INC.